News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Alterity Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
‘Holy Grail’ – Alterity Therapeutics aims to slow progression of Parkinson’s disease
News
Closing Bell: Intense relief as ASX rallies on easing inflation
News
Top 10 at 11: This morning’s news is about all the hot quarterly action you can handle
News
ASX Small Caps Lunch Wrap: Who’s been sunk by a poopy one-star review this week?
News
Closing Bell: Markets are in revolution and the ASX just stormed its psychological Bastille
News
Top 10 at 11: Half year results and legal woes are making news today
News
ASX Small Caps and IPO Weekly Wrap: The week we learned what Woolies is really worth
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps Lunch Wrap: Who’s realised their terrible Russian mistake this week?
Health & Biotech
Check Up: Aussie biotech Avarax on the verge of peanut allergy cure; and recent ASX health winners
News
Top 10 at 11: I hope everyone’s hungry for lithium, because it’s driving most of the news today
News
Top 10 at 11: It’s all pearls, primates, Parkinson’s and potash as far as the eye can see today
Health & Biotech
ASX Health Stocks: Compumedics granted FDA clearance; Botanix receives FDA feedback
Health & Biotech
ASX Health Stocks: Mesoblast partners up for pivotal trial, Alterity in $4.8 million cap raise
News
Top 10 at 11: Boardroom battles and spinning drills are driving the market this morning
News
Rise and Shine: Everything you need to know before the ASX opens
News
